<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03310723</url>
  </required_header>
  <id_info>
    <org_study_id>H17-01996</org_study_id>
    <nct_id>NCT03310723</nct_id>
  </id_info>
  <brief_title>Pre-Oxygenation Techniques in Pregnancy</brief_title>
  <acronym>POP</acronym>
  <official_title>A Comparison of Pre-oxygenation Techniques in Pregnant Patients Prior to a Cesarean Delivery - A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A trial comparing outcomes of two pre-oxygenation techniques in obstetric patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-oxygenation is performed prior to general anesthesia to prevent hypoxia during airway&#xD;
      management. It is typically performed using a standard tight-fitting face mask; however,&#xD;
      recent advances in oxygenation have occurred through the use of trans-nasal oxygen delivery&#xD;
      devices, such as OptiFlow. There is limited evidence of the use of OptiFlow in the pregnant&#xD;
      patient, and as such, this study aims to show that OptiFlow is as effective at&#xD;
      pre-oxygenation as a standard tight-fitting face-mask technique in the pregnant population.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 10, 2017</start_date>
  <completion_date type="Actual">January 18, 2018</completion_date>
  <primary_completion_date type="Actual">January 18, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>End Tidal Oxygen Concentration (ETO2) Following Tidal Volume Breathing Using Either Face Mask or OptiFlow</measure>
    <time_frame>From baseline ETO2 concentration to the end of 3 minutes of tidal volume breathing</time_frame>
    <description>Concentration of oxygen at the end of a breath following 3 minutes of tidal volume breathing using either face mask or OptiFlow</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>End Tidal Oxygen Concentration (ETO2) Following Vital Capacity Breaths Using Either Face Mask or OptiFlow</measure>
    <time_frame>From baseline ETO2 concentration to the end of 8 vital capacity breaths (approximately 3 minutes)</time_frame>
    <description>Concentration of oxygen at the end of a breath following 8 deep breaths using either face mask or OptiFlow</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Preoxygenation</condition>
  <arm_group>
    <arm_group_label>Standard Face Mask Preoxygenation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tidal volume breathing for via a face mask set at 100% oxygen and a rate of 15L/min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optiflow Preoxygenation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tidal volume breathing with the OptiFlow system applied at 100% oxygen and a flow rate of 30-70L/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Face Mask preoxygenation</intervention_name>
    <description>Standard face mask preoxygenation.</description>
    <arm_group_label>Standard Face Mask Preoxygenation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OptiFlow preoxygenation</intervention_name>
    <description>Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).</description>
    <arm_group_label>Optiflow Preoxygenation</arm_group_label>
    <other_name>THRIVE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy (American Society of Anesthesiologists class 1 or 2), pregnant patients ≥36&#xD;
             weeks gestation scheduled for elective Cesarean delivery under neuraxial anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Comorbidities likely to alter outcome of respiration and gas exchange.&#xD;
&#xD;
          -  Patients only able to breathe through their mouth.&#xD;
&#xD;
          -  Patients who are in active labour.&#xD;
&#xD;
          -  Patients unable to tolerate a face mask being held over their mouth and nose.&#xD;
&#xD;
          -  Patients with a Body Mass Index ≥40kg/m2.&#xD;
&#xD;
          -  Patients who are unable to give informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anton Chau, MD MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BC Women's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 4, 2017</study_first_submitted>
  <study_first_submitted_qc>October 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <results_first_submitted>February 25, 2019</results_first_submitted>
  <results_first_submitted_qc>September 12, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 16, 2020</results_first_posted>
  <last_update_submitted>September 12, 2020</last_update_submitted>
  <last_update_submitted_qc>September 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Anthony Chau</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 23, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/23/NCT03310723/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Face Mask Preoxygenation</title>
          <description>Tidal volume breathing via a face mask set at 100% oxygen and a rate of 15L/min.&#xD;
Face Mask preoxygenation: Standard face mask preoxygenation.</description>
        </group>
        <group group_id="P2">
          <title>Optiflow Preoxygenation</title>
          <description>Tidal volume breathing with the OptiFlow system applied at 100% oxygen and a flow rate of 30-70L/min.&#xD;
OptiFlow preoxygenation: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Face Mask Preoxygenation</title>
          <description>Tidal volume breathing for via a face mask set at 100% oxygen and a rate of 15L/min.&#xD;
Face Mask preoxygenation: Standard face mask preoxygenation.</description>
        </group>
        <group group_id="B2">
          <title>Optiflow Preoxygenation</title>
          <description>Tidal volume breathing with the OptiFlow system applied at 100% oxygen and a flow rate of 30-70L/min.&#xD;
OptiFlow preoxygenation: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="37"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.8" spread="4.3"/>
                    <measurement group_id="B2" value="34.6" spread="5.3"/>
                    <measurement group_id="B3" value="34.7" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline end-tidal oxygen concentration (EtO2)</title>
          <units>Percentage units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.9" spread="1.2"/>
                    <measurement group_id="B2" value="15.9" spread="1.5"/>
                    <measurement group_id="B3" value="15.9" spread="1.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>End Tidal Oxygen Concentration (ETO2) Following Tidal Volume Breathing Using Either Face Mask or OptiFlow</title>
        <description>Concentration of oxygen at the end of a breath following 3 minutes of tidal volume breathing using either face mask or OptiFlow</description>
        <time_frame>From baseline ETO2 concentration to the end of 3 minutes of tidal volume breathing</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Face Mask Preoxygenation</title>
            <description>Tidal volume breathing via a face mask set at 100% oxygen and a rate of 15L/min.&#xD;
Face Mask preoxygenation: Standard face mask preoxygenation.</description>
          </group>
          <group group_id="O2">
            <title>Optiflow Preoxygenation</title>
            <description>Tidal volume breathing with the OptiFlow system applied at 100% oxygen and a flow rate of 30-70L/min.&#xD;
OptiFlow preoxygenation: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).</description>
          </group>
        </group_list>
        <measure>
          <title>End Tidal Oxygen Concentration (ETO2) Following Tidal Volume Breathing Using Either Face Mask or OptiFlow</title>
          <description>Concentration of oxygen at the end of a breath following 3 minutes of tidal volume breathing using either face mask or OptiFlow</description>
          <units>Percentage units of end-tidal oxygen</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.0" lower_limit="89.3" upper_limit="92.7"/>
                    <measurement group_id="O2" value="87.4" lower_limit="85.5" upper_limit="89.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>End Tidal Oxygen Concentration (ETO2) Following Vital Capacity Breaths Using Either Face Mask or OptiFlow</title>
        <description>Concentration of oxygen at the end of a breath following 8 deep breaths using either face mask or OptiFlow</description>
        <time_frame>From baseline ETO2 concentration to the end of 8 vital capacity breaths (approximately 3 minutes)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Face Mask Preoxygenation</title>
            <description>Tidal volume breathing via a face mask set at 100% oxygen and a rate of 15L/min.&#xD;
Face Mask preoxygenation: Standard face mask preoxygenation.</description>
          </group>
          <group group_id="O2">
            <title>Optiflow Preoxygenation</title>
            <description>Tidal volume breathing with the OptiFlow system applied at 100% oxygen and a flow rate of 30-70L/min.&#xD;
OptiFlow preoxygenation: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).</description>
          </group>
        </group_list>
        <measure>
          <title>End Tidal Oxygen Concentration (ETO2) Following Vital Capacity Breaths Using Either Face Mask or OptiFlow</title>
          <description>Concentration of oxygen at the end of a breath following 8 deep breaths using either face mask or OptiFlow</description>
          <units>Percentage units</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.8" lower_limit="90.1" upper_limit="93.4"/>
                    <measurement group_id="O2" value="85.9" lower_limit="84.1" upper_limit="87.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected during study procedures (i.e., from baseline measurements to end of pre-oxygenation at 3 minutes).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Face Mask Preoxygenation</title>
          <description>Tidal volume breathing via a face mask set at 100% oxygen and a rate of 15L/min.&#xD;
Face Mask preoxygenation: Standard face mask preoxygenation.</description>
        </group>
        <group group_id="E2">
          <title>Optiflow Preoxygenation</title>
          <description>Tidal volume breathing with the OptiFlow system applied at 100% oxygen and a flow rate of 30-70L/min.&#xD;
OptiFlow preoxygenation: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Research Assistant</name_or_title>
      <organization>BC Women's Hospital, Department of Anesthesia</organization>
      <phone>604-875-2424 ext 6076</phone>
      <email>james.taylor1@phsa.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

